-
LY3214996
- names:
LY3214996
- CAS号:
1951483-29-6
MDL Number: - MF(分子式): C22H27N7O2S MW(分子量): 453.56
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | |
| 英文别名 | LY3214996 |
| CAS号 | 1951483-29-6 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C22H27N7O2S |
| 分子量 Molecular Weight | 453.56 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度20 mg/mL(44.10 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | LY3214996 is a highly selective inhibitor ofERK1andERK2, withIC50of 5 nM for both enzymes in biochemical assays. LY3214996 potently inhibits cellular p-RSK1 in BRAF and RAS mutant cancer cell lines. LY3214996 shows potent antitumor activities in cancer models with MAPK pathway alterations. |
| Application1 | |
| Application2 | |
| Application3 |
LY3214996 为高效的选择性ERK1和ERK2抑制剂,IC50为 5 nM。LY3214996 作用于 BRAF 和 RAS 突变癌细胞系中,有效抑制 p-RSK1。LY3214996 在 MAPK 途径改变的癌症模型中具有强大的抗肿瘤活性。LY3214996 is a highly selective inhibitor ofERK1andERK2, withIC50of 5 nM for both enzymes in biochemical assays. LY3214996 potently inhibits cellular p-RSK1 in BRAF and RAS mutant cancer cell lines. LY3214996 shows potent antitumor activities in cancer models with MAPK pathway alterations.
| 【1】.Shripad V. Bhagwat, et al. Abstract 4973: Discovery of LY3214996, a selective and novel ERK1/2 inhibitor with potent antitumor activities in cancer models with MAPK pathway alterations. Cancer Research. July 2017. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


